World's Best Scientists 2026 revealed!
Mark D. Stegall

Mark D. Stegall

D-Index & Metrics

Medicine

D-Index
99
Citations
31964
World Ranking
8675
National Ranking
4473

Overview

Mark D. Stegall is affiliated with the Mayo Clinic in the United States and has an extensive publication record primarily in the field of Medicine with a focus on transplantation. Their work includes research in transplant surgery, immunology, and related fields, contributing substantially to the knowledge base in renal and organ transplantation.

Their research spans several subfields including:

  • Transplantation
  • Surgery
  • Pulmonary and Respiratory Medicine
  • Public Health, Environmental and Occupational Health
  • Immunology

Marked topics of study in their publications cover:

  • Renal Transplantation Outcomes and Treatments
  • Organ Transplantation Techniques and Outcomes
  • Renal and Vascular Pathologies
  • Organ Donation and Transplantation
  • Transplantation: Methods and Outcomes
  • Pancreatic function and diabetes
  • Cytomegalovirus and herpesvirus research

Among the recent papers associated with Mark D. Stegall are:

  • The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell- and antibody-mediated rejection, 2020, American Journal of Transplantation
  • American Society of Transplant Surgeons recommendations on best practices in donation after circulatory death organ procurement, 2023, American Journal of Transplantation
  • Implication of TIGIT+ human memory B cells in immune regulation, 2021, Nature Communications
  • The Use of GLP1R Agonists for the Treatment of Type 2 Diabetes in Kidney Transplant Recipients, 2020, Transplantation Direct
  • Trajectories of glomerular filtration rate and progression to end stage kidney disease after kidney transplantation, 2020, Kidney International

Frequent co-authors in their collaborative research include:

  • Byron H. Smith
  • Walter D. Park
  • Carrie A. Schinstock
  • Aleksandra Kukla
  • Andrew Bentall

Their research has appeared in a variety of publication venues, with multiple contributions particularly in:

  • American Journal of Transplantation
  • Journal of the American Society of Nephrology
  • Transplantation
  • Clinical Transplantation
  • Mayo Clinic Proceedings

Best Publications

  • Risk factors for primary dysfunction after liver transplantation--a multivariate analysis.

    Rutger Ploeg;Anthony D'alessandro;Stuart Knechtle;Mark Stegall

  • The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials

    M. Haas;A. Loupy;C. Lefaucheur;C. Roufosse

  • Identifying Specific Causes of Kidney Allograft Loss

    Z. M. El-Zoghby;M. D. Stegall;D. J. Lager;W. K. Kremers

  • Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients.

    M. D. Stegall;T. Diwan;S. Raghavaiah;L. D. Cornell

  • The Banff 2019 Kidney Meeting Report (I): updates on and clarification of criteria for T cell- and antibody-mediated rejection

    Alexandre Loupy;Mark Haas;Candice Roufosse;Maarten Naesens

  • The Association Between Age and Nephrosclerosis on Renal Biopsy Among Healthy Adults

    Andrew D. Rule;Hatem Amer;Lynn D. Cornell;Sandra J. Taler

  • A Comparison of Plasmapheresis Versus High-Dose IVIG Desensitization in Renal Allograft Recipients with High Levels of Donor Specific Alloantibody

    M.D. Stegall;J. Gloor;J.L. Winters;S.B. Moore

  • Measured and estimated GFR in healthy potential kidney donors.

    Andrew D Rule;Hiie M Gussak;Gregory R Pond;Erik J Bergstralh

  • New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation

    Fernando G. Cosio;Yogish Kudva;Marije van der Velde;Timothy S. Larson

  • Proteasome inhibition causes apoptosis of normal human plasma cells preventing alloantibody production.

    D. K. Perry;J. M. Burns;H. S. Pollinger;B. P. Amiot

  • Transplant Glomerulopathy: Subclinical Incidence and Association with Alloantibody

    J. M. Gloor;S. Sethi;M. D. Stegall;W. D. Park

  • Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.

    Christopher Johnson;Nasimul Ahsan;Thomas Gonwa;Philip Halloran

  • Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus.

    Patrick G. Dean;William J. Lund;Timothy S. Larson;Mikel Prieto

  • Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors

    B. J. Orandi;X. Luo;A. B. Massie;J. M. Garonzik-Wang

  • Predicting subsequent decline in kidney allograft function from early surveillance biopsies.

    Fernando G. Cosio;Joseph P. Grande;Hani Wadei;Timothy S. Larson

  • Transplant Glomerulopathy

    F. G. Cosio;J. M. Gloor;S. Sethi;M. D. Stegall

  • Determinants of Discard of Expanded Criteria Donor Kidneys: Impact of Biopsy and Machine Perfusion

    R. S. Sung;Laura L. Christensen;Alan B. Leichtman;S. M. Greenstein

  • Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus.

    T. S. Larson;P. G. Dean;M. D. Stegall;M. D. Griffin

  • Overcoming a Positive Crossmatch in Living-Donor Kidney Transplantation

    James M. Gloor;Steven R. DeGoey;Alvaro A. Pineda;S. Breanndan Moore

  • Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation.

    J. M. Burns;L. D. Cornell;D. K. Perry;H. S. Pollinger

Frequent Co-Authors

Joseph P. Grande
Joseph P. Grande Mayo Clinic
Dorry L. Segev
Dorry L. Segev Johns Hopkins University
Robert A. Montgomery
Robert A. Montgomery New York University
Stuart J. Knechtle
Stuart J. Knechtle Duke University
Nelson Leung
Nelson Leung Mayo Clinic
Philip F. Halloran
Philip F. Halloran University of Alberta
Stanley C. Jordan
Stanley C. Jordan Cedars-Sinai Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine doesn't always require a traditional path. Many students and professionals now look for flexible, accelerated programs that can fast-track their journey. One popular option is the accelerated dnp programs, which allow nurses to earn a Doctor of Nursing Practice in less time without sacrificing quality.

If you’re seeking an easier entry point into advanced nursing, researching the easiest dnp program reddit discussions can provide genuine insights into student experiences and program demands. These online communities help prospective students find the best match for their needs and abilities.

For those starting their nursing journey, the lpn fast track program is designed to quickly launch your healthcare career as a Licensed Practical Nurse, a critical stepping-stone to more advanced roles.

Mental health is another growing field. The fastest psych np program provides a streamlined path to become a Psychiatric Mental Health Nurse Practitioner, responding to rising mental health needs across the country.

Best Scientists Citing Mark D. Stegall

Trending Scientists

Recently Published Articles